Lina Benson

Karolinska Institutet

Sweden

Research Interests

Explore related searches

Professors in Sweden

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (12)

Year:

2025

Year:

2025

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Collaborators (11)

Maria Generosa Crespo-Leiro

Profesor Titular de Medicina

Universidade da Coruña

SPAIN

View details

Benedikt Schrage

University Heart and Vascular Center

GERMANY

View details

Agnieszka Kapłon-Cieślicka

Medical University of Warsaw

POLAND

View details

Frieder Braunschweig

Director, professor

Sahlgrenska universitetssjukhuset

SWEDEN

View details

Gianfranco Sinagra

University of Trieste

ITALY

View details

Mark Petrie

University of Glasgow

UNITED KINGDOM

View details

Michael Melin

Karolinska Institutet

SWEDEN

View details

Cecilia LInde

Karolinska University Hospital

SWEDEN

View details

Raffaele Scorza

Karolinska Institutet

SWEDEN

View details

Alicia Uijl

Assistant professor

NETHERLANDS

View details

Lars H Lund

Karolinska University Hospital

SWEDEN

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Lina Benson

Research Interests

Explore related searches

Contact this professor

Articles (12)

Withdrawal of Guideline-Directed Medical Therapy in Patients With Heart Failure and Improved Ejection Fraction

Characterizing Heart Failure Across the Spectrum of the Preserved Ejection Fraction: Does Heart Failure With Supranormal Ejection Fraction Exist? Data From the Swedish Heart Failure Registry

Cardiac resynchronization therapy with or without defibrillator in patients with heart failure.

Patient profile and outcomes associated with follow-up in specialty vs. primary care in heart failure

Persistent High Burden of Heart Failure Across the Ejection Fraction Spectrum in a Nationwide Setting

A comprehensive characterization of acute heart failure with preserved versus mildly reduced versus reduced ejection fraction - insights from the ESC-HFA EORP Heart Failure Long-Term Registry

Apparent Treatment-Resistant Hypertension Across the Spectrum of Heart Failure Phenotypes in the Swedish HF Registry

Eligibility for dapagliflozin and empagliflozin in a real-world heart failure population

Eligibility of patients with heart failure with preserved ejection fraction for sacubitril/valsartan according to the PARAGON-HF trial

Predictors of primary prevention implantable cardioverter-defibrillator use in heart failure with reduced ejection fraction: impact of the predicted risk of sudden cardiac death and all-cause mortality

Use of evidence-based therapy in heart failure with reduced ejection fraction across age strata

A population-based study of post-endovascular aortic repair rupture during 15 years

Collaborators (11)

Maria Generosa Crespo-Leiro

Benedikt Schrage

Agnieszka Kapłon-Cieślicka

Frieder Braunschweig

Gianfranco Sinagra

Mark Petrie

Michael Melin

Cecilia LInde

Raffaele Scorza

Alicia Uijl

Lars H Lund

Make your next move.